% | $
Quotes you view appear here for quick access.

Take-Two Interactive Software Inc. Message Board

false 18 posts  |  Last Activity: Jun 18, 2015 8:10 PM Member since: Jul 16, 2012
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • false false Jun 18, 2015 8:10 PM Flag

    I can see you owning the stock and wanting to comment on it a few times a day. But 50 or 60 every day promoting and stalking others? That sounds like you are trying to con folks. I mean you have 4,400 plus posts in a little over a year. What's up with all that? Ocd? Lonely? Mentally unsound? Hypocritical projection? Frederic me and your mammie Are worried about you. Any of that gambling money left? Hope you didn't let those big wolves make a sheep out of you again like over at mudb

  • Reply to

    OPC11 recommends outstanding buy

    by brewman228 Jun 14, 2015 8:54 PM
    false false Jun 15, 2015 5:19 PM Flag

    Maybe you meant%

  • He is telling people not to short. Gives rules and tells people not to short stocks that seem overvalued. He Lso said don't short stocks that have a lot of other people shorting the same stock. He said don't short stocks thT might b

  • false by false May 22, 2015 10:47 PM Flag

    GE, Kofler Energies and BELECTRIC Take Highly Efficient Hybrid Power Plant into Operation

    BERLIN—May 13, 2015—GE (NYSE: GE) is putting a new, highly efficient hybrid power plant into operation in Berlin. With this pioneering concept, which offers scalable capacity, GE and its project partners Kofler Energies and BELECTRIC are breaking new ground in the area of innovative, decentralized energy supply. Representatives from the involved companies were joined by guests from the worlds of politics, business, and science to witness the launch of operations at the plant.

    The new hybrid power plant, which was developed by Kofler Energies and GE’s planning office BLS Energieplan, combines photovoltaic with flexible Jenbacher combined heat and power (CHP) technology and an innovative battery solution. Thanks to an intelligent energy management system and comprehensive operational oversight, the power output can be controlled to meet demands as efficiently as possible.

    The plant will not only supply power and heat to the GE Power Conversion production site in Marienfelde, Germany, but it also will feed power into the grid. The system is based on a scalable business model that also can be adapted for larger units.

    The centerpiece of the hybrid power plant is a Jenbacher J312 gas engine with integrated heat storage and an efficiency level of 89.2 percent. The 400 kW system covers the basic heat load of the site during the heating season and is fueled by energy-efficient natural gas. The plant enables primary energy savings of around 30 percent compared to systems that generate heat and power separately through conventional heating and external electricity procurement.

    A 600 kW solar power system with an operating voltage of 1,500 volts has been installed on the roof of the production hall. All measurement readings required for monitoring and controlling the complex system can be called up and managed remotely via the central energy management system.

    When the amount of power being generated is high but consumption is low, surplus power is stored in a battery with a capacity of 200 kWh. This can then be released and fed into the plant network as required to meet higher levels of demand, bringing flexibility to power generation. Surplus power only is supplied to the public grid if the battery is completely full.

    The boilers, pumps and valves are controlled in a way that ensures that the system always operates efficiently and in line with demand. The data recorded makes energy consumption transparent and can be used to help adjust the power supply to meet requirements to the

  • false false May 20, 2015 3:43 PM Flag

    Any idea why the big drop

  • Reply to

    Stem Cells Featured today by Major News outlets

    by dalek_kelad May 18, 2015 5:57 PM
    false false May 19, 2015 4:16 PM Flag

    The use of stem cells by athletes may become the norm someday. As drug companies conduct trials, reveal their safety and efficacy, and eventually gain FDA approval, the use of stem cells will rapidly gain traction among professional athletes. Just as reduction of inflammation is believed to decrease tissue ischemia and its negative effects in stroke patients, reduction of inflammation in muscular tissue restores proper cellular function and accelerates healing. Pluristem recently learned that an intramuscular injection of adult stem cells not only repaired the incised muscle faster than placebo, but also the contralateral side (non-surgical side) showed greater muscle force. The press release of its Phase I/II clinica

  • Williams Partners L.P. logo Williams Partners L.P. (NYSE:WPZ) was downgraded by research analysts at RB

  • Reply to

    What people don't seem to understand....

    by s.eranger May 6, 2015 10:04 AM
    false false May 7, 2015 4:11 PM Flag

    Not true in my case..I took a big loss on half the position last year, which wiped out my gains

  • false false Apr 25, 2015 8:32 PM Flag

    Jeffrey, due to my wife's brain injury and subsequent disability, I don't have the time to devote to researching stocks

  • Reply to

    timing is everything

    by alltorque700 Apr 24, 2015 8:17 PM
    false false Apr 24, 2015 9:30 PM Flag

    Getting an understanding of some mechanics of market maker and naked short selling

    Naked" Short Selling

    In a "naked" short sale, the seller does not borrow or arrange to borrow the securities in time to make delivery to the buyer within the standard three-day settlement period. As a result, the seller fails to deliver securities to the buyer when delivery is due (known as a "failure to deliver" or "fail").

    Failures to deliver may result from either a short or a long sale. There may be legitimate reasons for a failure to deliver. For example, human or mechanical errors or processing delays can result from transferring securities in physical certificate rather than book-entry form, thus causing a failure to deliver on a long sale within the normal three-day settlement period. A fail may also result from naked short selling. For example, market makers who sell short thinly traded, illiquid stock in response to customer demand may encounter difficulty in%

  • Reply to

    Marcellus Production

    by rainbow3100 Apr 22, 2015 6:20 PM
    false false Apr 23, 2015 5:02 PM Flag

    In the best areas of the Marcellus it costs $1,100 per lateral foot to drill a well and they supposedly recover or have an EUR of 2.1 BCF/1,000 feet. So a well with a 5,000 foot lateral costs $5,500,000 and has an EUR of 11 BCF. Total Return on this well with NG at a buck would be $11,000,000. Subtract out Royalties and Taxes of say 25% and the driller will get back 8.25 Million. Around 70 percent of total production will occur in the first 3 years netting the company $5,775,000. Corporate overhead, interest, depreciation, etc. need to be accounted for as well. It seems probable to me that this best of the best type well would not be profitable with NG at a buck.

    And I have some serious doubts about getting EUR of 2.1 BCF/1000 feet - a very select few wells will produce at this level if any.

    EOG is the only shale driller that I know of that has been positive cash flow in thei

  • Facebook is full of fake accounts, many of them are opened by pedophiles and by people who use fake names to troll and pretend to be other people. I attempted to report obvious fake accountd and Facebook never disabled them.I don't think advertisers are getting their monies worth considering that most adds are anoying and most people I know have never mentioned that they saw a new product on Facebook or were made aware of something because it was in Facebook. From what I see snapchat and instagram and taking away share from Facebook with t

  • false false Apr 13, 2015 6:09 PM Flag

    So ...roughly, device only needed to be around for approx 2 years for stability data and a single late stage trial. So call it 3 years. It can actually be quicker as UNS often state the materials in contact with the fluid path are all known materials so stability data should be a no brainer.

    But of course just because a device doesnt have to be used in all trials and the whole clinical program; doesnt mean that the pharma and the device company are not

  • Reply to

    Anyone doing some selling?

    by keebon Apr 7, 2015 1:17 PM
    false false Apr 7, 2015 4:31 PM Flag

    Keebon, a good question to ask and o

27.57-0.37(-1.32%)4:00 PMEDT